Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Strateos is a pioneering technology company that has been at the forefront of automating chemistry, biology, and data science to accelerate life science research and development. They are known for providing on-demand access to remote-controlled, automated laboratories (Robotic Cloud Labs) through a sophisticated web-based interface. This innovative approach allows scientists to design, execute, and analyze experiments from anywhere in the world, significantly enhancing efficiency, reproducibility, and data quality. Strateos's mission has been to transform traditional R&D labs into data-driven, AI-enabled discovery engines. In December 2023, Strateos was acquired by Multiply Labs, a company specializing in robotic manufacturing for pharmaceuticals. The integration aims to combine Strateos's automated experimentation capabilities with Multiply Labs' manufacturing technology to create a comprehensive, automated platform from drug discovery to production.
This facility serves as a core robotic cloud laboratory, equipped with advanced automated instrumentation for high-throughput chemistry and biology workflows, supporting R&D for a global clientele in pharma, biotech, and academia.
Features state-of-the-art robotic platforms, automated liquid handling systems, extensive analytical instrumentation, and environmentally controlled modules. All systems are integrated and accessible via Strateos's cloud-based software platform.
Prior to acquisition, the culture was characterized by a blend of rigorous scientific research and agile software development, fostering innovation, precision, and interdisciplinary collaboration. Post-acquisition by Multiply Labs, the culture is evolving to integrate with Multiply Labs' focus on robotic systems for pharmaceutical development and manufacturing.
The San Carlos facility is pivotal for delivering Strateos's core 'lab-as-a-service' offering. Its strategic location in the Bay Area provides access to specialized talent and proximity to a vibrant biotech ecosystem, crucial for its operations and collaborations.
Strateos's cloud-native platform enables scientists and research organizations worldwide to design, remotely execute, and monitor complex experiments in its automated US-based laboratories. While its physical lab infrastructure was located in California, its services, software, and data access were inherently global, catering to an international client base spanning pharmaceutical companies, biotech firms, and academic institutions. Strateos also engaged in collaborations to extend its technological footprint, including partnerships aimed at making automated research capabilities more accessible in regions like Asia.
303 Shoreway Rd, Suite B
San Carlos
CA
USA
Address: 1315 Adams Court, Suite A, Menlo Park, CA 94025 (Former Corporate HQ)
Strategically situated in Silicon Valley to leverage its rich ecosystem of tech talent, venture capital, and innovation networks.
Address: Operated a specialized facility (details may be integrated post-acquisition).
Leveraged San Diego's prominent biotechnology and pharmaceutical research cluster, particularly its strengths in chemistry and small molecule R&D.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Strateos' leadership includes:
Strateos has been backed by several prominent investors over the years, including:
The most significant executive changes for Strateos in the last 12-18 months relate to its acquisition by Multiply Labs in December 2023. This led to key Strateos leadership transitioning into new or advisory roles within Multiply Labs to guide the integration and continued development of the Strateos platform and technology.
Discover the tools Strateos uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Prior to its acquisition by Multiply Labs, Strateos likely utilized common corporate email formats such as [first initial][last name]@strateos.com or [first name].[last name]@strateos.com. For example, 'jdoe@strateos.com' or 'jane.doe@strateos.com'. Post-acquisition, communications may increasingly use Multiply Labs domain emails ([name]@multiplylabs.com), though legacy Strateos emails might remain active during transition.
[first_initial][last]@strateos.com or [first].[last]@strateos.com
Format
jsmith@strateos.com or john.smith@strateos.com (example)
Example
70%
Success rate
PR Newswire (via Multiply Labs) • December 5, 2023
Multiply Labs announced its acquisition of Strateos, Inc. The move aims to merge Strateos's advanced capabilities in automated experimentation and cloud-based laboratory control with Multiply Labs' robotic manufacturing technology for pharmaceuticals, thereby accelerating innovation across both drug discovery and manufacturing processes....more
Business Wire (via Strateos) • May 10, 2023
Strateos revealed a partnership with Ginkgo Bioworks focused on developing an automated, high-throughput solution for cell therapy manufacturing workflows. This collaboration intended to harness Strateos's robotic cloud lab infrastructure to enhance the efficiency, scalability, and reproducibility of cell therapy production....more
Business Wire (via Strateos) • February 28, 2023
Strateos introduced Lättis, an innovative automated execution system designed to optimize sample preparation and management for structural biology applications, particularly cryogenic electron microscopy (cryo-EM). The Lättis platform aimed to alleviate critical bottlenecks in structural biology research workflows by automating complex, manual tasks....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Strateos, are just a search away.